• This topic has 1 voice and 0 replies.
Viewing 0 reply threads
  • Author
    • #12038
      Forum Moderator

      Using a new screening strategy, researchers have identified compounds that block the clumping of alpha-synuclein protein, a key event in Parkinson’s. The study, “Potent α-Synuclein Aggregation Inhibitors, Identified by High-Throughput Screening, Mainly Target the Monomeric State,” appeared in the journal Cell Chemical Biology.

      Click here to read a summary of the study and its findings at ParkinsonsNewsToday.com

      What are your thoughts on this news? What other screenings tools have you heard about or used?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2022 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?

Create Account